Lung cancer study IDs new 'epigenomic' target for diagnosis and treatment

Lung cancer study IDs new 'epigenomic' target for diagnosis and treatment

Source: 
Fierce Biotech
snippet: 

As cancer cells evolve, their genes change in ways that lead tumors to become more aggressive and to spread throughout the body. While studying that process, scientists at the Massachusetts Institute of Technology and Harvard University discovered a protein that, when elevated in human lung tumors, portends a negative outcome—a finding that could point to new diagnostics and maybe even drug targets, they believe.